Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

1 new

Companies in a sound financial shape with a dividend yield of more than 5%.

3 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$49.65

-2.6%

4.3%

Allied Biotech

Market Cap: NT$2.3b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$23.75

2.8%

33.8%

TTY Biopharm

Market Cap: NT$18.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$74.40

-3.4%

-2.7%